K Pharma is a biotechnology company originating from Keio University School of Medicine. It uses induced pluripotent stem cells in two research areas: identifying drug candidates and developing regenerative-medicine products, with neurological disorders among its principal targets.
Its programs include drug development for amyotrophic lateral sclerosis based on joint research with Keio University School of Medicine, and iPS-cell regenerative approaches for subacute and chronic spinal-cord injury and stroke. In drug discovery it uses drug repositioning, testing approved medicines on disease-specific iPS cells to shorten development. Its laboratories are in Fujisawa, Kanagawa, and at Keio University.
0
open positions at K Pharma
No live listings from K Pharma right now — browse all Tokyo software jobs instead.